- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/10 - Tetrapeptides
Patent holdings for IPC class C07K 5/10
Total number of patents in this class: 764
10-year publication summary
|
32
|
46
|
50
|
50
|
43
|
46
|
35
|
26
|
20
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ISP Investments Inc. | 454 |
17 |
| The University of British Columbia | 1528 |
12 |
| Stealth Biotherapeutics Inc. | 167 |
12 |
| Stealth Biotherapeutics Corp | 36 |
11 |
| Bristol-myers Squibb Company | 4833 |
9 |
| Lipotec, S.A. | 208 |
9 |
| Helix Biomedix Inc. | 32 |
8 |
| Endocyte, Inc. | 110 |
7 |
| S.i.s. Shulov Innovative Science Ltd. | 15 |
7 |
| The Regents of the University of California | 20245 |
6 |
| CARA Therapeutics, Inc. | 48 |
6 |
| Mimetogen Pharmaceuticals, Inc. | 18 |
6 |
| Onyx Therapeutics, Inc. | 68 |
6 |
| Lactocore, Inc. | 7 |
6 |
| The Governing Council of The University of Toronto, | 1500 |
5 |
| Kyoto University | 2840 |
5 |
| Promis Neurosciences Inc. | 33 |
5 |
| Zedira GmbH | 37 |
5 |
| Centre National de La Recherche Scientifique | 10645 |
4 |
| California Institute of Technology | 3986 |
4 |
| Other owners | 614 |